Sen Meng

556 total citations
9 papers, 315 citations indexed

About

Sen Meng is a scholar working on Molecular Biology, Cancer Research and Pathology and Forensic Medicine. According to data from OpenAlex, Sen Meng has authored 9 papers receiving a total of 315 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Cancer Research and 1 paper in Pathology and Forensic Medicine. Recurrent topics in Sen Meng's work include Cancer-related molecular mechanisms research (6 papers), RNA modifications and cancer (4 papers) and Epigenetics and DNA Methylation (3 papers). Sen Meng is often cited by papers focused on Cancer-related molecular mechanisms research (6 papers), RNA modifications and cancer (4 papers) and Epigenetics and DNA Methylation (3 papers). Sen Meng collaborates with scholars based in China and India. Sen Meng's co-authors include Jin Bai, Pingfu Hou, Junnian Zheng, Tian Lin, Zhongwei Li, Sufang Chu, Minle Li, Yuming Gu, Meilin Shi and Tao Jiang and has published in prestigious journals such as Cell Death and Disease, Journal of Experimental & Clinical Cancer Research and International Journal of Biological Sciences.

In The Last Decade

Sen Meng

9 papers receiving 314 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sen Meng China 8 271 215 41 24 24 9 315
Guandi Wu China 7 301 1.1× 186 0.9× 35 0.9× 24 1.0× 17 0.7× 13 354
Siyuan Wu China 11 266 1.0× 212 1.0× 24 0.6× 24 1.0× 21 0.9× 24 321
Juanfei Peng China 9 218 0.8× 160 0.7× 58 1.4× 42 1.8× 21 0.9× 13 285
Jiali Long China 8 306 1.1× 262 1.2× 34 0.8× 25 1.0× 22 0.9× 12 371
Jinze Shen China 10 220 0.8× 179 0.8× 35 0.9× 34 1.4× 17 0.7× 26 274
Qingzhi Kong China 5 253 0.9× 202 0.9× 41 1.0× 39 1.6× 14 0.6× 9 306
Zhi Lu China 5 360 1.3× 350 1.6× 23 0.6× 21 0.9× 30 1.3× 7 416
Luyuan Ma China 8 188 0.7× 159 0.7× 50 1.2× 27 1.1× 31 1.3× 17 261
Guohua Zhang China 6 180 0.7× 166 0.8× 27 0.7× 27 1.1× 18 0.8× 7 230
Zheng Zhi China 6 283 1.0× 245 1.1× 25 0.6× 22 0.9× 16 0.7× 8 330

Countries citing papers authored by Sen Meng

Since Specialization
Citations

This map shows the geographic impact of Sen Meng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sen Meng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sen Meng more than expected).

Fields of papers citing papers by Sen Meng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sen Meng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sen Meng. The network helps show where Sen Meng may publish in the future.

Co-authorship network of co-authors of Sen Meng

This figure shows the co-authorship network connecting the top 25 collaborators of Sen Meng. A scholar is included among the top collaborators of Sen Meng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sen Meng. Sen Meng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Meng, Sen, Hao Liu, Sufang Chu, et al.. (2024). PRMT5-Mediated ALKBH5 Methylation Promotes Colorectal Cancer Immune Evasion via Increasing CD276 Expression. Research. 8. 549–549. 8 indexed citations
2.
Li, Zhongwei, Hongmei Yong, Lei Jiang, et al.. (2023). PRMT2 promotes RCC tumorigenesis and metastasis via enhancing WNT5A transcriptional expression. Cell Death and Disease. 14(5). 322–322. 22 indexed citations
3.
Meng, Sen, et al.. (2022). LncRNA LINC00460 facilitates the proliferation and metastasis of renal cell carcinoma via PI3K/AKT signaling pathway. Journal of Cancer. 13(9). 2844–2854. 5 indexed citations
4.
Chen, Xintian, Xueying Ji, Sen Meng, et al.. (2022). TRIM21 deficiency promotes cell proliferation and tumorigenesis via regulating p21 expression in ovarian cancer. Bioengineered. 13(3). 6024–6035. 14 indexed citations
5.
Hou, Pingfu, Sen Meng, Minle Li, et al.. (2021). LINC00460/DHX9/IGF2BP2 complex promotes colorectal cancer proliferation and metastasis by mediating HMGA1 mRNA stability depending on m6A modification. Journal of Experimental & Clinical Cancer Research. 40(1). 365–365. 161 indexed citations
6.
Wang, Bin, Kai Zhang, Sen Meng, et al.. (2021). LncRNA-NONHSAT024778 promote the proliferation and invasion of chordoma cell by regulating miR-1290/Robo1 axis. International Journal of Biological Sciences. 17(3). 796–806. 11 indexed citations
7.
Hou, Pingfu, Tian Lin, Sen Meng, et al.. (2021). Long noncoding RNA SH3PXD2A-AS1 promotes colorectal cancer progression by regulating p53-mediated gene transcription. International Journal of Biological Sciences. 17(8). 1979–1994. 10 indexed citations
8.
9.
Lin, Tian, Pingfu Hou, Sen Meng, et al.. (2019). Emerging Roles of p53 Related lncRNAs in Cancer Progression: A Systematic Review. International Journal of Biological Sciences. 15(6). 1287–1298. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026